Wana Brands teams up with Gofire
November 15th, 2019
Consumers can utilize Precision Dosing for Colorado’s Most Popular Terpene Blends
Boulder, Colo. (Nov. 14, 2019) — Wana Brands, America’s favorite infused product manufacturer, is bringing Colorado’s top selling distillate blends to Gofire’s SmartCartridge and patented Gofire Inhaler. Gofire™–an innovator of hardware and software solutions that aid in dose delivery, health tracking and medication management–enables precision dosing of Wana’s proprietary variety of classes including Sativa Lemon, Hybrid Berry and 1:1 Rose Gold.
“Wana’s partnership with Gofire is welcomed news for consumers that are looking for a consistent cannabis experience they can count on,” said Nancy Whiteman, CEO of Wana Brands. “Wana Brands is already No. 1 in Colorado thanks to the attention to detail in our proprietary terpene blends. Now Gofire’s technology enables consumers to replicate results by tracking their Wana experience through the Gofire Inhaler and App.”
Developed specifically for use in the Gofire Inhaler, the Gofire SmartCartridge enables the delivery of concentrate in precise, 2.5-mg increments while simultaneously sending dose information and the concentrate’s exact chemical makeup to Gofire’s personal phone app, where Wana customers can monitor and track their usage, allowing them to identify the outcomes they experience and ultimately to ascertain their preferred dosing regimen. Consumers can purchase Wana Brands SmartCartridges from Wana’s retail partners and use them with their Gofire Inhaler, which provides convection heating as well as temperature control in single-degree increments. Wana Brands SmartCartridges contain only cannabis distillate with reintroduced terpenes, and never any fillers or cutting agents.
- Wana Sativa Lemon is uplifting, motivating and stress relieving with a refreshingly zingy lemon flavor.
- Wana Hybrid Berry offers creative and uplifting effects and carries the aroma of real fruit. A great choice anytime, day or night.
- Wana CBD/THC 1:1 Rose Gold provides the benefits of the entourage effect with a distinct floral aroma and a clean, clear and balanced experience.
The Gofire Inhaler uses a patented extrusion process that draws product from the cartridge into the convection oven on a dose-by-dose basis. As a result, there’s no re-heating of the oil and no degradation over time, resulting in a more flavorful, enjoyable experience for recreational users and a more consistent medication delivery for medical marijuana patients.
“Wana Brands has established a reputation for consistency, quality and reliability,” said Peter Calfee, CEO of Gofire. “Gofire offers yet another option for consumers that are looking for consistent and replicable experiences, whether they are a patient seeking doctor-recommended medical relief or a recreational consumer seeking the highest-quality product.”
Wana’s SmartCartridge products are available in Colorado dispensaries.
Wana Brands: Enhance Your Life.
Included in the 2019 Inc. 5000 list at #1536 and boasting a three-year growth rate of 269%, Wana Brands is the No. 1 edibles brand in the United States, with more dollars sold than any other brand, according to BDS Analytics 2018 Brand Share Report. Wana leads the industry in quality, consistency and potency, providing a range of different options that enable customers to create the specific cannabis experience they want. Wana products offer diverse product forms including edibles, vapes and extended release capsules, four different CBD/THC ratios as well as a variety of different dosages, onset times and duration of effects. The portfolio is designed so products can be used singly or in combination to address specific health, wellness and recreational needs. Wana products are available in Colorado, Illinois, Michigan, Arizona, Nevada and Oregon dispensaries, with California, Ohio and Florida (as regulations allow) among the states imminently coming online. Wana Brands expects to expand internationally to Canada by 2020. For more information or to subscribe to Wana’s e-newsletter, visit www.wanabrands.com. Follow Wana on LinkedIn, Twitter, YouTube and Pinterest.
Gofire is a healthcare technology company developing a proprietary smart inhaler that pairs with a personal dosing app to allow patients to create consistent experiences with plant-based medicines. By removing the fear of taking too much while gaining the support of crowdsourced data, Gofire users find products best suited to their specific needs. Gofire is committed to making health resources safe and accessible through standardizing dose regimens by delivery method and by patient condition. Gofire is helping people realize the medicinal and therapeutic benefits of alternative health products through a new take on wellness innovation. Visit their website here, and follow Gofire on Facebook, Instagram and Twitter.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.